Lilly Asia Venture Invests $15M In MabSpace Biosciences’ Series A Round
October 29, 2015 — 11:37 CST
This Data Is Locked!
This area is available only to Subscribers.
Suzhou city, Jiangsu province-based MabSpace Biosciences, a start-up focused on developing antibody therapeutics for cancer treatment, has completed US$15 million series A round of financing... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals